Hisamitsu Pharmaceuticals develops percutaneous antihistamine patch for the treatment of allergic rhinitis

In a phase-III study in Japan, the „TransDermaSal“ technology of the company, a transdermal drug delivery system based on a systemic tape and doped with a second-generation antihistamine, proved superior to oral administration of the same antihistamine.

Hisamitsu Pharmaceuticals news release, July 25, 2016

Hisamitsu Pharmaceuticals develops percutaneous antihistamine patch for the treatment of allergic rhinitis
Scroll to top